Article
Utility of different massive parallel sequencing platforms for mutation profiling in clinical samples and identification of pitfalls using FFPE tissue.
International journal of molecular medicine - 1 Nov 2015
Fassunke Jana, Haller Florian, Hebele Simone, Moskalev Evgeny A, Penzel Roland, Pfarr Nicole, Merkelbach-Bruse Sabine, Endris Volker
Abstract excerpt
In the growing field of personalised medicine, the analysis of numerous potential targets is becoming a challenge in terms of work load, tissue availability, as well as costs. The molecular analysis of non-small cell lung cancer (NSCLC) has shifted from the analysis of the epidermal growth factor receptor (EGFR) mutation status to the analysis of different gene regions, including resistance mutations or...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
